• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氨基噻唑揭示脯氨酰寡肽酶的一个新配体结合位点,该位点对于调节其蛋白-蛋白相互作用衍生功能很重要。

5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions.

机构信息

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.

Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.

出版信息

J Med Chem. 2024 Apr 11;67(7):5421-5436. doi: 10.1021/acs.jmedchem.3c01993. Epub 2024 Mar 28.

DOI:10.1021/acs.jmedchem.3c01993
PMID:38546708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11394002/
Abstract

A series of novel 5-aminothiazole-based ligands for prolyl oligopeptidase (PREP) comprise selective, potent modulators of the protein-protein interaction (PPI)-mediated functions of PREP, although they are only weak inhibitors of the proteolytic activity of PREP. The disconnected structure-activity relationships are significantly more pronounced for the 5-aminothiazole-based ligands than for the earlier published 5-aminooxazole-based ligands. Furthermore, the stability of the 5-aminothiazole scaffold allowed exploration of wider substitution patterns than that was possible with the 5-aminooxazole scaffold. The intriguing structure-activity relationships for the modulation of the proteolytic activity and PPI-derived functions of PREP were elaborated by presenting a new binding site for PPI modulating PREP ligands, which was initially discovered using molecular modeling and later confirmed through point mutation studies. Our results suggest that this new binding site on PREP is clearly more important than the active site of PREP for the modulation of its PPI-mediated functions.

摘要

一系列新型 5-氨基噻唑基配体是脯氨酰寡肽酶(PREP)的选择性、强效调节剂,尽管它们只是 PREP 的蛋白-蛋白相互作用(PPI)介导功能的弱抑制剂。与早期发表的 5-氨基恶唑基配体相比,5-氨基噻唑基配体的不相关结构-活性关系更为明显。此外,5-氨基噻唑骨架的稳定性允许探索比 5-氨基恶唑骨架更广泛的取代模式。通过呈现一个新的结合位点来阐述 PREP 的蛋白水解活性和 PPI 衍生功能的调节的有趣的结构-活性关系,该结合位点最初是使用分子建模发现的,后来通过点突变研究得到了证实。我们的结果表明,对于 PREP 的 PPI 介导功能的调节,这个新的结合位点显然比 PREP 的活性位点更为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/422c2a8075b4/jm3c01993_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/9f0217d0fe33/jm3c01993_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/a77084571c83/jm3c01993_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/6aa092b4b07b/jm3c01993_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/882d98304dff/jm3c01993_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/bc3d4ce87ac9/jm3c01993_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/b668b2d7c8c8/jm3c01993_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/422c2a8075b4/jm3c01993_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/9f0217d0fe33/jm3c01993_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/a77084571c83/jm3c01993_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/6aa092b4b07b/jm3c01993_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/882d98304dff/jm3c01993_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/bc3d4ce87ac9/jm3c01993_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/b668b2d7c8c8/jm3c01993_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8361/11394002/422c2a8075b4/jm3c01993_0006.jpg

相似文献

1
5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions.5-氨基噻唑揭示脯氨酰寡肽酶的一个新配体结合位点,该位点对于调节其蛋白-蛋白相互作用衍生功能很重要。
J Med Chem. 2024 Apr 11;67(7):5421-5436. doi: 10.1021/acs.jmedchem.3c01993. Epub 2024 Mar 28.
2
Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson's Disease.基于噁唑的非肽脯氨酰寡肽酶配体对帕金森病α-突触核蛋白小鼠模型具有疾病修饰作用。
J Med Chem. 2023 Jun 8;66(11):7475-7496. doi: 10.1021/acs.jmedchem.3c00235. Epub 2023 May 29.
3
Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.脯氨酰寡肽酶的抑制通过减少小鼠脑中的α-突触核蛋白寡聚体,恢复基于α-突触核蛋白病毒载体的帕金森病小鼠模型中的自发运动行为。
J Neurosci. 2016 Dec 7;36(49):12485-12497. doi: 10.1523/JNEUROSCI.2309-16.2016.
4
The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy.脯氨酰寡肽酶抑制剂对α-突触核蛋白聚集和自噬的影响不能通过其抑制效果来预测。
Biomed Pharmacother. 2020 Aug;128:110253. doi: 10.1016/j.biopha.2020.110253. Epub 2020 May 22.
5
Study of the Conformational Dynamics of Prolyl Oligopeptidase by Mass Spectrometry: Lessons Learned.用质谱法研究脯氨酰寡肽酶的构象动力学:经验教训。
J Med Chem. 2024 Jun 27;67(12):10436-10446. doi: 10.1021/acs.jmedchem.4c00866. Epub 2024 May 24.
6
Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.脯氨酰寡肽酶通过直接的蛋白质-蛋白质相互作用增强α-突触核蛋白二聚化。
J Biol Chem. 2015 Feb 20;290(8):5117-5126. doi: 10.1074/jbc.M114.592931. Epub 2015 Jan 2.
7
The prolyl oligopeptidase family.脯氨酰寡肽酶家族。
Cell Mol Life Sci. 2002 Feb;59(2):349-62. doi: 10.1007/s00018-002-8427-5.
8
The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.脯氨酰寡肽酶抑制剂KYP-2047对A30P转基因小鼠α-突触核蛋白清除和自噬的有益作用。
Neurobiol Dis. 2014 Aug;68:1-15. doi: 10.1016/j.nbd.2014.04.003. Epub 2014 Apr 16.
9
Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors.脯氨酰寡肽酶在人外周组织及卵巢和结直肠肿瘤中的分布。
J Histochem Cytochem. 2012 Sep;60(9):706-15. doi: 10.1369/0022155412453051. Epub 2012 Jun 26.
10
Inhibition-mediated changes in prolyl oligopeptidase dynamics possibly related to α-synuclein aggregation.抑制介导的脯氨酰寡肽酶动力学变化可能与α-突触核蛋白聚集有关。
Phys Chem Chem Phys. 2022 Feb 16;24(7):4366-4373. doi: 10.1039/d1cp05238a.

引用本文的文献

1
Structural visualization of inhibitor binding in prolyl oligopeptidase.脯氨酰寡肽酶中抑制剂结合的结构可视化
Biophys Rev (Melville). 2024 Aug 22;5(3):032105. doi: 10.1063/5.0226428. eCollection 2024 Sep.
2
Study of the Conformational Dynamics of Prolyl Oligopeptidase by Mass Spectrometry: Lessons Learned.用质谱法研究脯氨酰寡肽酶的构象动力学:经验教训。
J Med Chem. 2024 Jun 27;67(12):10436-10446. doi: 10.1021/acs.jmedchem.4c00866. Epub 2024 May 24.

本文引用的文献

1
Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson's Disease.基于噁唑的非肽脯氨酰寡肽酶配体对帕金森病α-突触核蛋白小鼠模型具有疾病修饰作用。
J Med Chem. 2023 Jun 8;66(11):7475-7496. doi: 10.1021/acs.jmedchem.3c00235. Epub 2023 May 29.
2
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.脯氨酰寡肽酶抑制剂可减轻细胞模型和患tau蛋白病小鼠的tau病理变化。
Sci Transl Med. 2023 Apr 12;15(691):eabq2915. doi: 10.1126/scitranslmed.abq2915.
3
Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.
帕金森病和其他突触核蛋白病中的阿尔法-突触核蛋白:从明显的神经退行性变回到早期突触功能障碍。
Cell Death Dis. 2023 Mar 1;14(3):176. doi: 10.1038/s41419-023-05672-9.
4
PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability.早发性帕金森病伴智力障碍患者中 PTPA 变异和 PP2A 活性受损。
Brain. 2023 Apr 19;146(4):1496-1510. doi: 10.1093/brain/awac326.
5
Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model.在基于病毒载体的帕金森病小鼠模型中,蛋白酶 K 抗性 αSyn 物种的去除与细胞存活无关。
Neuropharmacology. 2022 Nov 1;218:109213. doi: 10.1016/j.neuropharm.2022.109213. Epub 2022 Aug 12.
6
Inhibition-mediated changes in prolyl oligopeptidase dynamics possibly related to α-synuclein aggregation.抑制介导的脯氨酰寡肽酶动力学变化可能与α-突触核蛋白聚集有关。
Phys Chem Chem Phys. 2022 Feb 16;24(7):4366-4373. doi: 10.1039/d1cp05238a.
7
2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors.用2-咪唑作为亲电基团的替代物可得到高效的脯氨酰寡肽酶抑制剂。
ACS Med Chem Lett. 2021 Sep 17;12(10):1578-1584. doi: 10.1021/acsmedchemlett.1c00399. eCollection 2021 Oct 14.
8
Prolyl oligopeptidase inhibition reduces oxidative stress via reducing NADPH oxidase activity by activating protein phosphatase 2A.脯氨酰寡肽酶抑制通过激活蛋白磷酸酶 2A 降低 NADPH 氧化酶活性来减少氧化应激。
Free Radic Biol Med. 2021 Jun;169:14-23. doi: 10.1016/j.freeradbiomed.2021.04.001. Epub 2021 Apr 7.
9
Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.KYP-2407 通过抑制脯氨酰寡肽酶增加神经元样细胞中α-突触核蛋白纤维的降解。
Biomed Pharmacother. 2020 Nov;131:110788. doi: 10.1016/j.biopha.2020.110788. Epub 2020 Sep 25.
10
The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy.脯氨酰寡肽酶抑制剂对α-突触核蛋白聚集和自噬的影响不能通过其抑制效果来预测。
Biomed Pharmacother. 2020 Aug;128:110253. doi: 10.1016/j.biopha.2020.110253. Epub 2020 May 22.